Executive Leadership
Harry Hoffman
Chief Executive Officer
Harry Hoffman is the Chief Executive Officer and co-founder of Aurea Theranostics, a biotechnology company targeting tumor recurrence. Prior to founding Aurea Theranostics, Harry studied molecular neuroscience at Ohio State University and cancer stem cells at Case Western Reserve University where he completed his M.S. in Pathology. As a third-generation entrepreneur, he has several years of experience in executive management and business development.
Andrew Crofton
Chief Operating Officer
Andrew Crofton is the Chief Operating Officer and co-founder of Aurea Theranostics. His scientific experience spans a wide array of fields including cancer immunotherapy, neuroscience, drug delivery, biomarker validation and nanotechnology. Andrew has been actively developing cancer therapeutics for over 10 years. He received his B.A. in Chemistry from St. Olaf College and PhD in Clinical Anatomy from Loma Linda University School of Medicine.